The UK’s vaccine programme has been vital in combatting COVID-19. In April 2020, CPI joined the UK Government’s Vaccine Taskforce to support the manufacture and formulation of novel mRNA vaccine candidates in the fight against the virus.
The UK’s vaccine programme has been vital in combatting COVID-19. In April 2020, CPI joined the UK Government’s Vaccine Taskforce to support the manufacture and formulation of novel mRNA vaccine candidates in the fight against the virus. Using its facility in Darlington, CPI played a key role in the development, scale-up, manufacture and supply of the vaccine being developed at Imperial College London. Following on from this work, CPI received a further investment of £5m from the UK Government to establish a ‘library’ of mRNA vaccines. The library will help in the fight against new COVID-19 variants and ensure that new vaccines can be rapidly scaled-up and manufactured for clinical trials. This work is helping to protect people and the economy in the longer term.
"*" indicates required fields
CASE STUDY
Like other parts of the UK, Scotland’s critical NHS supply chains were under extreme pressure in 2020. The NMIS-AFRC stepped forward, as part of a Scottish Government led working group, to make sure that supplies were maintained.
3 February 2022
CASE STUDY
Dental aerosol protection equipment to safeguard against airborne particles
To help address this, the MTC has developed ‘Halo’. Designed to protect dentistry staff and patients against contaminated aerosol particles, it provides up to 99% protection when used in conjunction with standard dental high-volume extraction equipment.
3 February 2022
CASE STUDY
Leading the Ventilator Challenge
On the 16th of March 2020, the Government asked UK industry to support the NHS in its fight against COVID-19. The VentilatorChallengeUK (VCUK) Consortium, led by the HVM Catapult’s outgoing CEO Dick Elsy and made up of more than 33 businesses from the aerospace, automotive and medical sectors, came together at speed to build medical ventilators.
3 February 2022